Year archive

BIOTRON LIMITED — 2024 filings

All 35 regulatory filings released by BIOTRON LIMITED (BIT) in 2024, sourced directly from the official regulator.

35 Filings

2024 Period

2024 filings (35)

Filing	Released	Lang
Presentation to Annual General Meeting 20 pages 2.3MB Regulatory Filings	2024-11-27	English
Results of Meeting AGM 2 pages 157.6KB Regulatory Filings	2024-11-27	English
Final Director's Interest Notice S.P. $ S.L. 5 pages 258.4KB Regulatory Filings	2024-11-27	English
Change of Director's Interest Notice M.M, M.H, R.T. 7 pages 275.6KB Regulatory Filings	2024-11-27	English
Agreement with C14 Consulting Group 2 pages 181.3KB Regulatory Filings	2024-11-26	English
Application for quotation of securities - BIT 20 pages 431.0KB Regulatory Filings	2024-11-24	English
Application for quotation of securities - BIT 6 pages 18.1KB Regulatory Filings	2024-11-18	English
Revised Continuous Disclosure Policy 9 pages 519.0KB Regulatory Filings	2024-11-14	English
Application for quotation of securities - BIT 6 pages 18.1KB Regulatory Filings	2024-11-11	English
Cancel - Application for quotation of securities - BIT 6 pages 17.7KB Regulatory Filings	2024-11-11	English
Application for quotation of securities - BIT 6 pages 18.1KB Regulatory Filings	2024-11-11	English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 1.1MB Regulatory Filings	2024-10-29	English
Typographical error 1 page 131.7KB Regulatory Filings	2024-10-24	English
Option Expiry Notice 4 pages 932.5KB Regulatory Filings	2024-10-23	English
Annual Report/Notice of AGM/Proxy Form 59 pages 2.6MB Regulatory Filings	2024-10-21	English
$1.8M R&D Rebate Received 2 pages 409.8KB Regulatory Filings	2024-10-13	English
Response to ASX Aware Query 11 pages 1.6MB Regulatory Filings	2024-09-24	English
BIT225-012 PHASE 2 COVID-19 CLINICAL TRIAL 4 pages 555.1KB Regulatory Filings	2024-09-05	English
Full Year Statutory Accounts and Appendix 4E 54 pages 2.0MB Regulatory Filings	2024-08-29	English
Corporate Governance Statement 9 pages 259.1KB Regulatory Filings	2024-08-29	English
Appendix 4G 13 pages 329.6KB Regulatory Filings	2024-08-29	English
Application for quotation of securities - BIT 6 pages 18.1KB Regulatory Filings	2024-08-14	English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 1.1MB Regulatory Filings	2024-07-30	English
Application for quotation of securities - BIT 6 pages 18.1KB Regulatory Filings	2024-07-21	English
Letter to Shareholders 3 pages 1.0MB Regulatory Filings	2024-07-10	English
Webinar Investors Presentation 12 pages 4.2MB Regulatory Filings	2024-06-25	English
BIOTRON CLINICAL TRIAL RESULTS WEBINAR 1 page 849.3 Regulatory Filings	2024-06-24	English
BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives 3 pages 729.3KB Regulatory Filings	2024-06-18	English
Change of Share Registry address 1 page 101.0KB Regulatory Filings	2024-05-22	English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 1.1MB Regulatory Filings	2024-04-25	English
POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV 3 pages 688.2KB Regulatory Filings	2024-04-04	English
Response to ASX Price Query 3 pages 475.6KB Regulatory Filings	2024-03-26	English
Half Yearly Report and Accounts 21 pages 796.3KB Regulatory Filings	2024-02-26	English
$1.64M R&D rebate received 2 pages 280.7KB Regulatory Filings	2024-02-07	English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 362.3KB Regulatory Filings	2024-01-29	English

Filings by year

2026 12 filings
2025 82 filings
2024 35 filings
2023 32 filings
2022 38 filings
2021 22 filings
2020 30 filings
2019 38 filings
2018 61 filings
2017 37 filings
2016 26 filings
2015 32 filings
2014 33 filings
2013 27 filings
2012 28 filings
2011 41 filings
2010 29 filings
2009 26 filings
2008 17 filings
2007 25 filings
2006 26 filings
2005 21 filings
2004 24 filings
2003 20 filings
2002 2 filings